Ind-Swift Laboratories Cash Flow
- Market cap
- ₹3,073 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹254.77 – ₹477.70
In the year ended FY25, Ind-Swift Laboratories generated ₹184 crore from operating activities, invested ₹123 crore and paid out ₹46.09 crore on financing activities. Net cash flow for the year was ₹15.36 crore. Free cash flow was ₹76.82 crore.
Ind-Swift Laboratories cash flow statement
Financial years, newest first. Negative figures are cash outflows.
| Item | FY25 |
|---|---|
| Cash from operating activities | 184 |
| Cash from investing activities | -123 |
| Cash from financing activities | -46.09 |
| Net cash flow | 15.36 |
| Capital expenditure | 108 |
| Free cash flow | 76.82 |
Source: Company filings, in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Ind-Swift Laboratories cash flow — frequently asked questions
What is Ind-Swift Laboratories' operating cash flow?
Ind-Swift Laboratories' cash flow from operating activities was ₹184 crore in the year ended FY25.
What is Ind-Swift Laboratories' free cash flow?
Ind-Swift Laboratories' free cash flow — operating cash flow minus capital expenditure — was ₹76.82 crore in FY25, after capital expenditure of ₹108 crore.
How much did Ind-Swift Laboratories spend on investing activities?
Net cash used in investing activities was ₹123 crore in FY25. This covers capital expenditure, acquisitions and the purchase or sale of investments.
Same Data For Peers
Trade Ind-Swift Laboratories With ATS
Track INDSWFTLAB live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.